BMY bms.com: Nilai bisnis marang pendapatan

Simbol resmi perusahaan Bristol Myers Squibb (BMY)

Bristol-Myers Squibb (BMY) maintains a strong research staff despite current workforce optimization. This EV/Sales chart visualizes the fair value boundaries of the asset, while the 3026.65 level captures recent values. Management is actively combating patent cliffs through mergers, and the environmental strategy is based on implementing green chemistry methods to reduce harmful emissions.

BMY Bristol-Myers Squibb: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

BMY (bms.com): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
- data kapitalisasi saham perusahaan:
- data saldo dhuwit lan arus kas:
Analisis wiwitan perusahaan:Bristol Myers Squibb - BMY
Produk sing diprodhuksi Bristol-Myers Squibb

Market valuation stability is critical for Bristol-Myers Squibb (BMY) due to prolonged drug development cycles and patent protection. The EV/Sales ratio combines market capitalization and net debt, comparing the total enterprise value to annual revenue. Low volatility in this metric confirms the maturity of cash flows, although a prolonged sideways trend may signal a loss of market interest in the company's innovative potential.